| Mrs Lisa Gaye Dolan, RN | |
|
69 Avenue B, Boone County Of Educations, Madison, WV 25130 | |
| (304) 369-3131 | |
| Not Available |
| Full Name | Mrs Lisa Gaye Dolan |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 69 Avenue B, Madison, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386710028 | NPI | - | NPPES |
| 3810003838 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 39176 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lisa Gaye Dolan, RN 5 Babe Lane, Holly Hills, Madison, WI 25130 Ph: (304) 369-6525 | Mrs Lisa Gaye Dolan, RN 69 Avenue B, Boone County Of Educations, Madison, WV 25130 Ph: (304) 369-3131 |
News Archive
Ob Hospitalist Group and Beazley, a leading insurer of hospital professional liability risks in the Lloyd's Insurance market, have created a unique partnership that is sure to bring forth many new and exciting opportunities, the very first of which is an up to 10% discount on insurance premiums Beazley is offering to OBHG hospital partners.
Genzyme, a Sanofi company announced today that key data from the TOWER trial were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
In two ancillary studies of two multi-center international clinical trials led by the University of Southern California Eye Institute, the injectable drug ocriplasmin appears to improve vision among patients suffering from symptomatic vitreomacular adhesion (VMA), a condition related to the aging eye that could cause permanent vision loss if left untreated.
IRIN looks at a planned U.N. initiative to combat early childhood malnutrition and the questions surrounding it.
The epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) are involved in the carcinogenesis of many malignancies. Therapeutic molecules targeting EGFR and HER2 have been successfully used for the treatment of colorectal, breast, lung and head and neck cancers among others.
› Verified 3 days ago
Kelly Jean Jarrell, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 69 Avenue B, Madison, WV 25130 Phone: 304-369-3131 | |
Linda Cabell, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 69 Avenue B, Madison, WV 25130 Phone: 304-369-3131 | |
Cynthia Pettry, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 69 Avenue B, Madison, WV 25130 Phone: 304-369-3131 Fax: 304-369-6789 | |
Ashley Johnson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 69 Avenue B, Madison, WV 25130 Phone: 304-766-7655 Fax: 304-755-2824 | |
Rachel Loftus, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 264 Jackson Ave, Madison, WV 25130 Phone: 304-784-1672 | |
Donna Sue Peros, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 69 Avenue B, Madison, WV 25130 Phone: 304-369-3131 Fax: 304-369-6789 |